<DOC>
	<DOCNO>NCT00606203</DOCNO>
	<brief_summary>Depression one important psychiatric sequela stroke . The prevalence post stroke depression ( PSD ) approximately 20-40 % . Depression comorbid stroke find associate increased disability , cognitive function decline , poor rehabilitation outcome high mortality rate.We go conduct trial prevention psot stroke depression prescribe milnacipran advance .</brief_summary>
	<brief_title>Dose Milnacipran Prevent Depressive Symptoms Patients With Acute Stroke ?</brief_title>
	<detailed_description>First visit ( visit 0 ) perform first three day patient admitted neurological ward due ischemic stroke . The purpose initial assessment include demographic data collection ( age , gender , stroke location ) , initial interview exclude past history depression , substance abuse psychosis . In addition , Ham-D , CGI , NIHSS , Barthel index , MMSE ( please refer `` instrument '' list ) perform first visit . Patients whose MMSE &lt; 15 Ham-D &gt; 10 exclude . After enrolled , patient stratify stroke location randomize assign two group : group A ( treatment group active antidepressant ) group B ( placebo group ) . Variables age , gender , severity NIHSS , MMSE Ham-D control assignment cytokine level check also baseline . The cytokine check include IL-1 , IL-6 , TNF-α , IFN-γ consider pro-inflammatory cytokine . The anti-inflammatory cytokine IL-4 , IL-10 TGF-β check also .Patients group A take Milnacipran ( 50mg ) 1 # QD first day enrol study titrate 1 # BID one week later . Patients group follow 1st , 3rd , 6th , 9th , 12th month stroke . The Ham-D , TDQ , NIHSS , Barthel index , CGI , MMSE cytokine assess check point . Patients either group A group B withdrawn study refer psychiatric clinic alternative management develop depression ( Ham-D &gt; 17 ) . Cytokine level depress patient compare randomly select control group . All interviewer blind patient 's medication . If patient drop , reason clarify record . Patients suffer recurrent stroke study period still keep protocol follow continuously one year unless patient request withdrawal</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Milnacipran</mesh_term>
	<criteria>Consecutive admission due first recurrent ischemic stroke ( image prove ) stroke occur precede 4 week admission . The onset stroke define occurrence abnormal neurological symptom accord patient ' statement . The following period 12 month include ( first third study aim ) , follow another 24 month study immunological aspect PSD ( second study aim ) . TIA ( transit ischemic attack ) Impairment communication cognitive function ( MMSE &lt; 15 ) Past history depression , psychosis , severe substance abuse Taking antidepressant least 2 week prior stroke Concurrent possible depression ( HamD &gt; 10 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>